December 9th 2022
Nicholas C. Rohs, MD, discusses databases of uncommon mutations in non–small cell lung cancer
Joshua K. Sabari, MD, discusses the importance of timely testing for uncommon mutations in non–small cell lung cancer.
December 15th 2022
Charu Aggarwal, MD, MPH, discusses treating patients with EGFR-mutant non–small cell lung cancer.